Business Sun Pharma, Dr. Reddy’s, Zydus, Glenmark roll out generic Semaglutide March 21, 2026 gopalkumarthakur@gmail.com The generic drugmakers, with many more expected to make announcements, are eyeing a share of the market for Semaglutide in India, which is estimated to be $1 billion over the next couple of years Related posts: How to plan for 10X rise in education expenses Next decade is defining period for India’s energy transition, says Premier Energies Anti-dumping probe opened on TB drug ethambutol hydrochloride Centre announces scheme to promote research in textiles
